The SPECTRUM conference, presented by leading national and international experts, offers participants a comprehensive review of a variety of oncologic diseases combined with the latest developments in medical, interventional and surgical therapeutic options.
Management of Hepatocellular Carcinoma in the Era of Molecular and Immune Treatments - May 22
Metastatic Colorectal Cancer (mCRC) - June 5
Musculoskeletal (MSK) / Genitourinary (GU) - June 19
Pancreatic Cancer - July 10 (Open vs Laparoscopic Whipple; Current Standards for Systemic Therapy and Future Directions; MR LINAC TRIAL; In Situ IRE vs Margin Accentuation; Percutaneous Pancreatic IRE; Immune Response Post IRE – What’s New)
Embolization Spectrum - July 22 (Triaging the HCC Patient for Locoregional Therapy; Embolics of Today and Tomorrow; Growing Applications of Cone Beam CT; Bland Embolization – Techniques; Conventional TACE Done Right; Economic Considerations in TACE; Effects of Bead Size and Doxorubicin Loading On Cellular Injury; Radio-opaque Beads; TACE / Beads / Y-90 in Cholangiocarcinoma; DEBIRI – Technical Considerations & Results; Breaking Down Y-90 Dosimetry; Anatomic Considerations in Y-90; Radiation Segmentectomy – Patient Selection, Technique and Results; Y-90 in an OBL Setting)
Ablation Spectrum - July 31 (Introduction to Microwave and Cryoablation; IRE Overview; RFA the Time-Tested Option; Microwave Ablation in HCC – When and How; RFA in m-CRC; Percutaneous Microwave Ablation In m-CRC; Overview of IRE in m-CRC; IRE in the Pancreas; Microwave Ablation in Pancreatic Cancer; Microwave vs Cryoablation in the Kidney; Practical Approach to Renal Ablation; Stereotactic Thermal Ablation of Liver Tumors; Cryoablation in Breast/Thyroid Cancer; Attacking GBM – Head On)
Format: Didactic lectures, interactive live panel discussions, instructive case-based reviews and Tumor Boards.
17 AMA PRA Category 1 Credits™ - maximum
24 CNE contact hours
May 22 - July 31, 2021